John Bicket, 10% Owner, Director, Executive Vice President, Chief Technology Officer, on July 21, 2026, sold 263,900 shares in Samsara (IOT) for $9,534,065. Following the Form 4 filing with the SEC, Bicket has control over a total of 2,052,305 Class A common shares of the company, with 501,510 shares held directly and 1,550,795 controlled indirectly.
SEC Filing:
Ludmila Smolyansky, Member of 10% Owner Group, on July 22, 2026, sold 100,000 shares in Lifeway Foods (LWAY) for $3,011,400. Following the Form 4 filing with the SEC, Smolyansky has control over a total of 507,207 common shares of the company, with 507,207 controlled indirectly.SEC Filing:https://www.sec.gov/Archives/edgar/data/814586/000168316826005734/xslF345X05/ownership.xml
Martine A Rothblatt, Director, Chairperson & CEO, on July 22, 2026, sold 9,500 shares in United Therapeutics (UTHR) for $5,040,380. Following the Form 4 filing with the SEC, Rothblatt has control over a total of 748,828 common shares of the company, with 40,513 shares held directly and 708,315 controlled indirectly.SEC Filing:https://www.sec.gov/Archives/edgar/data/1082554/000110657826000104/xslF345X05/primarydocument.xml
Nancy Koskey Patzwahl, Director, on July 22, 2026, executed a purchase for 25,000 shares in Rhinebeck Bancorp (RBKB) for $298,500. Following the Form 4 filing with the SEC, Patzwahl has control over a total of 27,270 common shares of the company, with 27,270 shares held directly.SEC Filing:https://www.sec.gov/Archives/edgar/data/1751783/000143774926024324/xslF345X05/rdgdoc.xml